| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 11 |
| 1 | RITONAVIR | 10 |
| 2 | ATAZANAVIR | 8 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 8 |
| 4 | LOPINAVIR AND RITONAVIR | 5 |
| 5 | ETANERCEPT | 4 |
| 6 | PREDNISONE | 4 |
| 7 | RALTEGRAVIR | 4 |
| 8 | ERGOCALCIFEROL | 3 |
| 9 | FOLIC ACID | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 11 | 0.0014 |
| 1 | RALTEGRAVIR | 4 | 0.0008 |
| 2 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| 3 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | 1 | 0.0006 |
| 4 | ATAZANAVIR | 8 | 0.0006 |
| 5 | ETRAVIRINE | 2 | 0.0005 |
| 6 | LOPINAVIR AND RITONAVIR | 5 | 0.0004 |
| 7 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 8 | ZIDOVUDINE | 3 | 0.0003 |
| 9 | ELETRIPTAN HYDROBROMIDE | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 15 | 0.0003 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 15 | 0.0002 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0001 |
| 5 | Cannabinoid [EPC] | 1 | 0.0001 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Progesterone [EPC] | 1 | 0.0000 |